The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation of arsenic trioxide, for the treatment of acute promyelocytic leukemia (APL), an aggressive ...

Decrease seen in percent of patients receiving timely treatment among those living in states with least stringent regulations.

Researchers sought to determine the effectiveness of patient navigation for younger breast cancer patients, and their attendance to referrals.

Researchers determined the predictive value of the Geriatric 8 Screening tool for OS and PFS in older patients with ...

Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.

Drs Dean Ornish and Peter Carroll presented their research on the effects of an intensive lifestyle program on outcomes for ...

An interim analysis of the prospective BIOPSTAGE trial determined optimal PET thresholds for SUVmax and SUVratio that ...

Investigator sought to determine whether nelfinavir mesylate plus chemoradiation and image-guided brachytherapy could improve disease-free survival for patients with stage III cervical cancer.

In this retrospective study, researchers explored mortality among women with breast cancer in states with and without Medicaid expansion.

No increase in risk for breast cancer seen for BRCA carriers following predominantly surgical menopause. HealthDay News — Use ...

In this phase 2 study, researchers aimed to determine whether adding elraglusib to gemcitabine and nab-paclitaxel improved survival in patients with treatment-naïve metastatic PDAC.

The investigational cortisol modulator relacorilant plus nab-paclitaxel improved survival in platinum-resistant ovarian ...